Machine Learning Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI Business Wire Mar 21, 2023 Funding supports the distribution of Artera’s flagship test in prostate cancer, as well as further test development across cancers Artera, the…
Machine Learning Artera Announces Positive Results Around Its Multimodal Artificial Intelligence (MMAI) Prognostic… Business Wire Feb 17, 2023 Validated across six phase III randomized trials, the biomarker demonstrated the ability to help enable personalized, shared decision-making for…